APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Preclinical Testing Service

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Preclinical Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

8 January 2026194 pages

Choose your research edition.

Industry ResearchPreclinical Testing Service Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Preclinical Testing Service Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Preclinical Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Preclinical Testing Service Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Preclinical Testing Service Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Preclinical Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Preclinical Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Preclinical Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Preclinical Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Preclinical Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Preclinical Testing Service include Charles River Laboratories, Eurofins Scientific, NorthEast BioAnalytical Laboratories LLC., GCMI, Altogen Labs, American Preclinical Services, ABL, VIMTA and Medicilon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Preclinical Testing Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Preclinical Testing Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Preclinical Testing Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Preclinical Testing Service market size, projected growth trends, production technologies, key applications, and end-use industries.

Preclinical Testing Service Segment by Company

Charles River Laboratories

Eurofins Scientific

NorthEast BioAnalytical Laboratories LLC.

GCMI

Altogen Labs

American Preclinical Services

ABL

VIMTA

Medicilon

ALTASCIENCES

Labcorp

ARL Bio Pharma

Absorption Systems

WuXi AppTec

IDEXX Laboratories, Inc.

LEVEL Biotechnology

Viroclinics-DDL

Albany Molecular Research Inc.

Preclinical Testing Service Segment by Type

Analytical Method Development Services

Drug Testing Services

Drug Contract Biological Testing Services

Drug Pharmacodynamic Testing Services

Preclinical Toxicology Testing Services

Other

Preclinical Testing Service Segment by Application

Laboratory

Medicine

Other

Preclinical Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Preclinical Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Preclinical Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Preclinical Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Preclinical Testing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Preclinical Testing Service industry.

Chapter 3: Detailed analysis of Preclinical Testing Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Preclinical Testing Servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Preclinical Testing Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Analytical Method Development Services Table 3. Key Players of Drug Testing Services Table 4. Key Players of Drug Contract Biological Testing Services Table 3. Key Players of Drug Pharmacodynamic Testing Services Table 4. Key Players of Preclinical Toxicology Testing Services Table 5. Key Players of Other Table 6. Global Preclinical Testing Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 7. Key Players of Laboratory Table 8. Key Players of Medicine Table 9. Key Players of Other Table 10. Global Preclinical Testing Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Preclinical Testing Service Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Preclinical Testing Service Market Share by Region (2021-2026) Table 13. Global Preclinical Testing Service Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Preclinical Testing Service Market Share by Region (2027-2032) Table 15. Preclinical Testing Service Industry Trends Table 16. Preclinical Testing Service Industry Drivers Table 17. Preclinical Testing Service Industry Opportunities and Challenges Table 18. Preclinical Testing Service Industry Restraints Table 19. Global Preclinical Testing Service Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Preclinical Testing Service Revenue Market Share by Company (2021-2026) Table 21. Global Preclinical Testing Service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Preclinical Testing Service Key Company Head Office and Area Served Table 23. Global Preclinical Testing Service Company, Product Type & Application Table 24. Global Preclinical Testing Service Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Preclinical Testing Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Preclinical Testing Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Preclinical Testing Service Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Preclinical Testing Service Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Preclinical Testing Service Revenue Market Share by Type (2021-2026) Table 31. Global Preclinical Testing Service Revenue Market Share by Type (2027-2032) Table 32. Global Preclinical Testing Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Preclinical Testing Service Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Preclinical Testing Service Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Preclinical Testing Service Revenue Market Share by Application (2021-2026) Table 36. Global Preclinical Testing Service Revenue Market Share by Application (2027-2032) Table 37. Charles River Laboratories Company Information Table 38. Charles River Laboratories Business Overview Table 39. Charles River Laboratories Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Charles River Laboratories Preclinical Testing Service Product Portfolio Table 41. Charles River Laboratories Recent Development Table 42. Eurofins Scientific Company Information Table 43. Eurofins Scientific Business Overview Table 44. Eurofins Scientific Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Eurofins Scientific Preclinical Testing Service Product Portfolio Table 46. Eurofins Scientific Recent Development Table 47. NorthEast BioAnalytical Laboratories LLC. Company Information Table 48. NorthEast BioAnalytical Laboratories LLC. Business Overview Table 49. NorthEast BioAnalytical Laboratories LLC. Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. NorthEast BioAnalytical Laboratories LLC. Preclinical Testing Service Product Portfolio Table 51. NorthEast BioAnalytical Laboratories LLC. Recent Development Table 52. GCMI Company Information Table 53. GCMI Business Overview Table 54. GCMI Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. GCMI Preclinical Testing Service Product Portfolio Table 56. GCMI Recent Development Table 57. Altogen Labs Company Information Table 58. Altogen Labs Business Overview Table 59. Altogen Labs Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Altogen Labs Preclinical Testing Service Product Portfolio Table 61. Altogen Labs Recent Development Table 62. American Preclinical Services Company Information Table 63. American Preclinical Services Business Overview Table 64. American Preclinical Services Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. American Preclinical Services Preclinical Testing Service Product Portfolio Table 66. American Preclinical Services Recent Development Table 67. ABL Company Information Table 68. ABL Business Overview Table 69. ABL Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. ABL Preclinical Testing Service Product Portfolio Table 71. ABL Recent Development Table 72. VIMTA Company Information Table 73. VIMTA Business Overview Table 74. VIMTA Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. VIMTA Preclinical Testing Service Product Portfolio Table 76. VIMTA Recent Development Table 77. Medicilon Company Information Table 78. Medicilon Business Overview Table 79. Medicilon Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Medicilon Preclinical Testing Service Product Portfolio Table 81. Medicilon Recent Development Table 82. ALTASCIENCES Company Information Table 83. ALTASCIENCES Business Overview Table 84. ALTASCIENCES Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. ALTASCIENCES Preclinical Testing Service Product Portfolio Table 86. ALTASCIENCES Recent Development Table 87. Labcorp Company Information Table 88. Labcorp Business Overview Table 89. Labcorp Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Labcorp Preclinical Testing Service Product Portfolio Table 91. Labcorp Recent Development Table 92. ARL Bio Pharma Company Information Table 93. ARL Bio Pharma Business Overview Table 94. ARL Bio Pharma Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. ARL Bio Pharma Preclinical Testing Service Product Portfolio Table 96. ARL Bio Pharma Recent Development Table 97. Absorption Systems Company Information Table 98. Absorption Systems Business Overview Table 99. Absorption Systems Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. Absorption Systems Preclinical Testing Service Product Portfolio Table 101. Absorption Systems Recent Development Table 102. WuXi AppTec Company Information Table 103. WuXi AppTec Business Overview Table 104. WuXi AppTec Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. WuXi AppTec Preclinical Testing Service Product Portfolio Table 106. WuXi AppTec Recent Development Table 107. IDEXX Laboratories, Inc. Company Information Table 108. IDEXX Laboratories, Inc. Business Overview Table 109. IDEXX Laboratories, Inc. Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 110. IDEXX Laboratories, Inc. Preclinical Testing Service Product Portfolio Table 111. IDEXX Laboratories, Inc. Recent Development Table 112. LEVEL Biotechnology Company Information Table 113. LEVEL Biotechnology Business Overview Table 114. LEVEL Biotechnology Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 115. LEVEL Biotechnology Preclinical Testing Service Product Portfolio Table 116. LEVEL Biotechnology Recent Development Table 117. Viroclinics-DDL Company Information Table 118. Viroclinics-DDL Business Overview Table 119. Viroclinics-DDL Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 120. Viroclinics-DDL Preclinical Testing Service Product Portfolio Table 121. Viroclinics-DDL Recent Development Table 122. Albany Molecular Research Inc. Company Information Table 123. Albany Molecular Research Inc. Business Overview Table 124. Albany Molecular Research Inc. Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 125. Albany Molecular Research Inc. Preclinical Testing Service Product Portfolio Table 126. Albany Molecular Research Inc. Recent Development Table 127. North America Preclinical Testing Service Market Size by Type (2021-2026) & (US$ Million) Table 128. North America Preclinical Testing Service Market Size by Type (2027-2032) & (US$ Million) Table 129. North America Preclinical Testing Service Market Size by Application (2021-2026) & (US$ Million) Table 130. North America Preclinical Testing Service Market Size by Application (2027-2032) & (US$ Million) Table 131. North America Preclinical Testing Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. North America Preclinical Testing Service Market Size by Country (2021-2026) Table 133. North America Preclinical Testing Service Market Size by Country (2027-2032) Table 134. Europe Preclinical Testing Service Market Size by Type (2021-2026) & (US$ Million) Table 135. Europe Preclinical Testing Service Market Size by Type (2027-2032) & (US$ Million) Table 136. Europe Preclinical Testing Service Market Size by Application (2021-2026) & (US$ Million) Table 137. Europe Preclinical Testing Service Market Size by Application (2027-2032) & (US$ Million) Table 138. Europe Preclinical Testing Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Preclinical Testing Service Market Size by Country (2021-2026) Table 140. Europe Preclinical Testing Service Market Size by Country (2027-2032) Table 141. China Preclinical Testing Service Market Size by Type (2021-2026) & (US$ Million) Table 142. China Preclinical Testing Service Market Size by Type (2027-2032) & (US$ Million) Table 143. China Preclinical Testing Service Market Size by Application (2021-2026) & (US$ Million) Table 144. China Preclinical Testing Service Market Size by Application (2027-2032) & (US$ Million) Table 145. Asia Preclinical Testing Service Market Size by Type (2021-2026) & (US$ Million) Table 146. Asia Preclinical Testing Service Market Size by Type (2027-2032) & (US$ Million) Table 147. Asia Preclinical Testing Service Market Size by Application (2021-2026) & (US$ Million) Table 148. Asia Preclinical Testing Service Market Size by Application (2027-2032) & (US$ Million) Table 149. Asia Preclinical Testing Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia Preclinical Testing Service Market Size by Country (2021-2026) Table 151. Asia Preclinical Testing Service Market Size by Country (2027-2032) Table 152. South America, Middle East & Africa Preclinical Testing Service Market Size by Type (2021-2026) & (US$ Million) Table 153. South America, Middle East & Africa Preclinical Testing Service Market Size by Type (2027-2032) & (US$ Million) Table 154. South America, Middle East & Africa Preclinical Testing Service Market Size by Application (2021-2026) & (US$ Million) Table 155. South America, Middle East & Africa Preclinical Testing Service Market Size by Application (2027-2032) & (US$ Million) Table 156. South America, Middle East & Africa Preclinical Testing Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. South America, Middle East & Africa Preclinical Testing Service Market Size by Country (2021-2026) Table 158. South America, Middle East & Africa Preclinical Testing Service Market Size by Country (2027-2032) Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Preclinical Testing Service Product Image Figure 2. Global Preclinical Testing Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Preclinical Testing Service Market Share by Type: 2025 VS 2032 Figure 4. Analytical Method Development Services Image Figure 5. Drug Testing Services Image Figure 6. Drug Contract Biological Testing Services Image Figure 7. Drug Pharmacodynamic Testing Services Image Figure 8. Preclinical Toxicology Testing Services Image Figure 9. Other Image Figure 10. Global Preclinical Testing Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 11. Global Preclinical Testing Service Market Share by Application: 2025 VS 2032 Figure 12. Laboratory Image Figure 13. Medicine Image Figure 14. Other Image Figure 15. Global Preclinical Testing Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 17. Global Preclinical Testing Service Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Preclinical Testing Service Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Preclinical Testing Service Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Preclinical Testing Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Preclinical Testing Service Revenue Market Share by Type (2021-2032) Figure 24. Global Preclinical Testing Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Preclinical Testing Service Revenue Market Share by Application (2021-2032) Figure 26. North America Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 27. North America Preclinical Testing Service Market Share by Type (2021-2032) Figure 28. North America Preclinical Testing Service Market Share by Application (2021-2032) Figure 29. North America Preclinical Testing Service Market Share by Country (2021-2032) Figure 30. United States Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 31. Canada Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 33. Europe Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 34. Europe Preclinical Testing Service Market Share by Type (2021-2032) Figure 35. Europe Preclinical Testing Service Market Share by Application (2021-2032) Figure 36. Europe Preclinical Testing Service Market Share by Country (2021-2032) Figure 37. Germany Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 38. France Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 40. Italy Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 41. Russia Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 43. China Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 44. China Preclinical Testing Service Market Share by Type (2021-2032) Figure 45. China Preclinical Testing Service Market Share by Application (2021-2032) Figure 46. Asia Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 47. Asia Preclinical Testing Service Market Share by Type (2021-2032) Figure 48. Asia Preclinical Testing Service Market Share by Application (2021-2032) Figure 49. Asia Preclinical Testing Service Market Share by Country (2021-2032) Figure 50. Japan Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 54. India Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 55. Australia Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Preclinical Testing Service Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Preclinical Testing Service Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Preclinical Testing Service Market Share by Country (2021-2032) Figure 60. Brazil Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 65. UAE Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 67. Chile Preclinical Testing Service Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Analytical Method Development Services
  • Drug Testing Services
  • Drug Contract Biological Testing Services
  • Drug Pharmacodynamic Testing Services
  • Preclinical Toxicology Testing Services
  • Other
Applications
  • Laboratory
  • Medicine
  • Other
Companies covered
  • Charles River Laboratories
  • Eurofins Scientific
  • NorthEast BioAnalytical Laboratories LLC.
  • GCMI
  • Altogen Labs
  • American Preclinical Services
  • ABL
  • VIMTA
  • Medicilon
  • ALTASCIENCES
  • Labcorp
  • ARL Bio Pharma
  • Absorption Systems
  • WuXi AppTec
  • IDEXX Laboratories, Inc.
  • LEVEL Biotechnology
  • Viroclinics-DDL
  • Albany Molecular Research Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Preclinical Testing Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Analytical Method Development Services
  5. 1.2.3 Drug Testing Services
  6. 1.2.4 Drug Contract Biological Testing Services
  7. 1.2.5 Drug Pharmacodynamic Testing Services
  8. 1.2.6 Preclinical Toxicology Testing Services
  9. 1.2.7 Other
  10. 1.3 Market Analysis by Application
  11. 1.3.1 Global Preclinical Testing Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  12. 1.3.2 Laboratory
  13. 1.3.3 Medicine
  14. 1.3.4 Other
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Preclinical Testing Service Growth Trends by Region
  17. 1.5.1 Global Preclinical Testing Service Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Preclinical Testing Service Market Size by Region (2021-2026)
  19. 1.5.3 Preclinical Testing Service Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Preclinical Testing Service Market Dynamics
  1. 2.1 Preclinical Testing Service Industry Trends
  2. 2.2 Preclinical Testing Service Industry Drivers
  3. 2.3 Preclinical Testing Service Industry Opportunities and Challenges
  4. 2.4 Preclinical Testing Service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Preclinical Testing Service Revenue by Company (2021-2026)
  2. 3.2 Global Preclinical Testing Service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Preclinical Testing Service Key Company Head office and Area Served
  4. 3.4 Global Preclinical Testing Service Company, Product Type & Application
  5. 3.5 Global Preclinical Testing Service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Preclinical Testing Service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Preclinical Testing Service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Preclinical Testing Service Tier 1, Tier 2, and Tier 3
4 Preclinical Testing Service Market by Type
  1. 4.1 Global Preclinical Testing Service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Preclinical Testing Service Market Size by Type (2021-2032)
  3. 4.3 Global Preclinical Testing Service Market Size Share by Type (2021-2032)
5 Preclinical Testing Service Market by Application
  1. 5.1 Global Preclinical Testing Service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Preclinical Testing Service Market Size by Application (2021-2032)
  3. 5.3 Global Preclinical Testing Service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Charles River Laboratories
  2. 6.1.1 Charles River Laboratories Company Information
  3. 6.1.2 Charles River Laboratories Business Overview
  4. 6.1.3 Charles River Laboratories Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Charles River Laboratories Preclinical Testing Service Product Portfolio
  6. 6.1.5 Charles River Laboratories Recent Developments
  7. 6.2 Eurofins Scientific
  8. 6.2.1 Eurofins Scientific Company Information
  9. 6.2.2 Eurofins Scientific Business Overview
  10. 6.2.3 Eurofins Scientific Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Eurofins Scientific Preclinical Testing Service Product Portfolio
  12. 6.2.5 Eurofins Scientific Recent Developments
  13. 6.3 NorthEast BioAnalytical Laboratories LLC.
  14. 6.3.1 NorthEast BioAnalytical Laboratories LLC. Company Information
  15. 6.3.2 NorthEast BioAnalytical Laboratories LLC. Business Overview
  16. 6.3.3 NorthEast BioAnalytical Laboratories LLC. Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 NorthEast BioAnalytical Laboratories LLC. Preclinical Testing Service Product Portfolio
  18. 6.3.5 NorthEast BioAnalytical Laboratories LLC. Recent Developments
  19. 6.4 GCMI
  20. 6.4.1 GCMI Company Information
  21. 6.4.2 GCMI Business Overview
  22. 6.4.3 GCMI Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 GCMI Preclinical Testing Service Product Portfolio
  24. 6.4.5 GCMI Recent Developments
  25. 6.5 Altogen Labs
  26. 6.5.1 Altogen Labs Company Information
  27. 6.5.2 Altogen Labs Business Overview
  28. 6.5.3 Altogen Labs Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Altogen Labs Preclinical Testing Service Product Portfolio
  30. 6.5.5 Altogen Labs Recent Developments
  31. 6.6 American Preclinical Services
  32. 6.6.1 American Preclinical Services Company Information
  33. 6.6.2 American Preclinical Services Business Overview
  34. 6.6.3 American Preclinical Services Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 American Preclinical Services Preclinical Testing Service Product Portfolio
  36. 6.6.5 American Preclinical Services Recent Developments
  37. 6.7 ABL
  38. 6.7.1 ABL Company Information
  39. 6.7.2 ABL Business Overview
  40. 6.7.3 ABL Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 ABL Preclinical Testing Service Product Portfolio
  42. 6.7.5 ABL Recent Developments
  43. 6.8 VIMTA
  44. 6.8.1 VIMTA Company Information
  45. 6.8.2 VIMTA Business Overview
  46. 6.8.3 VIMTA Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 VIMTA Preclinical Testing Service Product Portfolio
  48. 6.8.5 VIMTA Recent Developments
  49. 6.9 Medicilon
  50. 6.9.1 Medicilon Company Information
  51. 6.9.2 Medicilon Business Overview
  52. 6.9.3 Medicilon Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Medicilon Preclinical Testing Service Product Portfolio
  54. 6.9.5 Medicilon Recent Developments
  55. 6.10 ALTASCIENCES
  56. 6.10.1 ALTASCIENCES Company Information
  57. 6.10.2 ALTASCIENCES Business Overview
  58. 6.10.3 ALTASCIENCES Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 ALTASCIENCES Preclinical Testing Service Product Portfolio
  60. 6.10.5 ALTASCIENCES Recent Developments
  61. 6.11 Labcorp
  62. 6.11.1 Labcorp Company Information
  63. 6.11.2 Labcorp Business Overview
  64. 6.11.3 Labcorp Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Labcorp Preclinical Testing Service Product Portfolio
  66. 6.11.5 Labcorp Recent Developments
  67. 6.12 ARL Bio Pharma
  68. 6.12.1 ARL Bio Pharma Company Information
  69. 6.12.2 ARL Bio Pharma Business Overview
  70. 6.12.3 ARL Bio Pharma Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 ARL Bio Pharma Preclinical Testing Service Product Portfolio
  72. 6.12.5 ARL Bio Pharma Recent Developments
  73. 6.13 Absorption Systems
  74. 6.13.1 Absorption Systems Company Information
  75. 6.13.2 Absorption Systems Business Overview
  76. 6.13.3 Absorption Systems Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Absorption Systems Preclinical Testing Service Product Portfolio
  78. 6.13.5 Absorption Systems Recent Developments
  79. 6.14 WuXi AppTec
  80. 6.14.1 WuXi AppTec Company Information
  81. 6.14.2 WuXi AppTec Business Overview
  82. 6.14.3 WuXi AppTec Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 WuXi AppTec Preclinical Testing Service Product Portfolio
  84. 6.14.5 WuXi AppTec Recent Developments
  85. 6.15 IDEXX Laboratories, Inc.
  86. 6.15.1 IDEXX Laboratories, Inc. Company Information
  87. 6.15.2 IDEXX Laboratories, Inc. Business Overview
  88. 6.15.3 IDEXX Laboratories, Inc. Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 IDEXX Laboratories, Inc. Preclinical Testing Service Product Portfolio
  90. 6.15.5 IDEXX Laboratories, Inc. Recent Developments
  91. 6.16 LEVEL Biotechnology
  92. 6.16.1 LEVEL Biotechnology Company Information
  93. 6.16.2 LEVEL Biotechnology Business Overview
  94. 6.16.3 LEVEL Biotechnology Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 LEVEL Biotechnology Preclinical Testing Service Product Portfolio
  96. 6.16.5 LEVEL Biotechnology Recent Developments
  97. 6.17 Viroclinics-DDL
  98. 6.17.1 Viroclinics-DDL Company Information
  99. 6.17.2 Viroclinics-DDL Business Overview
  100. 6.17.3 Viroclinics-DDL Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Viroclinics-DDL Preclinical Testing Service Product Portfolio
  102. 6.17.5 Viroclinics-DDL Recent Developments
  103. 6.18 Albany Molecular Research Inc.
  104. 6.18.1 Albany Molecular Research Inc. Company Information
  105. 6.18.2 Albany Molecular Research Inc. Business Overview
  106. 6.18.3 Albany Molecular Research Inc. Preclinical Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Albany Molecular Research Inc. Preclinical Testing Service Product Portfolio
  108. 6.18.5 Albany Molecular Research Inc. Recent Developments
7 North America
  1. 7.1 North America Preclinical Testing Service Market Size (2021-2032)
  2. 7.2 North America Preclinical Testing Service Market Size by Type
  3. 7.2.1 North America Preclinical Testing Service Market Size by Type (2021-2026)
  4. 7.2.2 North America Preclinical Testing Service Market Size by Type (2027-2032)
  5. 7.2.3 North America Preclinical Testing Service Market Share by Type (2021-2032)
  6. 7.3 North America Preclinical Testing Service Market Size by Application
  7. 7.3.1 North America Preclinical Testing Service Market Size by Application (2021-2026)
  8. 7.3.2 North America Preclinical Testing Service Market Size by Application (2027-2032)
  9. 7.3.3 North America Preclinical Testing Service Market Share by Application (2021-2032)
  10. 7.4 North America Preclinical Testing Service Market Size by Country
  11. 7.4.1 North America Preclinical Testing Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Preclinical Testing Service Market Size by Country (2021-2026)
  13. 7.4.3 North America Preclinical Testing Service Market Size by Country (2027-2032)
  14. 7.4.4 North America Preclinical Testing Service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Preclinical Testing Service Market Size (2021-2032)
  2. 8.2 Europe Preclinical Testing Service Market Size by Type
  3. 8.2.1 Europe Preclinical Testing Service Market Size by Type (2021-2026)
  4. 8.2.2 Europe Preclinical Testing Service Market Size by Type (2027-2032)
  5. 8.2.3 Europe Preclinical Testing Service Market Share by Type (2021-2032)
  6. 8.3 Europe Preclinical Testing Service Market Size by Application
  7. 8.3.1 Europe Preclinical Testing Service Market Size by Application (2021-2026)
  8. 8.3.2 Europe Preclinical Testing Service Market Size by Application (2027-2032)
  9. 8.3.3 Europe Preclinical Testing Service Market Share by Application (2021-2032)
  10. 8.4 Europe Preclinical Testing Service Market Size by Country
  11. 8.4.1 Europe Preclinical Testing Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Preclinical Testing Service Market Size by Country (2021-2026)
  13. 8.4.3 Europe Preclinical Testing Service Market Size by Country (2027-2032)
  14. 8.4.4 Europe Preclinical Testing Service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Preclinical Testing Service Market Size (2021-2032)
  2. 9.2 China Preclinical Testing Service Market Size by Type
  3. 9.2.1 China Preclinical Testing Service Market Size by Type (2021-2026)
  4. 9.2.2 China Preclinical Testing Service Market Size by Type (2027-2032)
  5. 9.2.3 China Preclinical Testing Service Market Share by Type (2021-2032)
  6. 9.3 China Preclinical Testing Service Market Size by Application
  7. 9.3.1 China Preclinical Testing Service Market Size by Application (2021-2026)
  8. 9.3.2 China Preclinical Testing Service Market Size by Application (2027-2032)
  9. 9.3.3 China Preclinical Testing Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Preclinical Testing Service Market Size (2021-2032)
  2. 10.2 Asia Preclinical Testing Service Market Size by Type
  3. 10.2.1 Asia Preclinical Testing Service Market Size by Type (2021-2026)
  4. 10.2.2 Asia Preclinical Testing Service Market Size by Type (2027-2032)
  5. 10.2.3 Asia Preclinical Testing Service Market Share by Type (2021-2032)
  6. 10.3 Asia Preclinical Testing Service Market Size by Application
  7. 10.3.1 Asia Preclinical Testing Service Market Size by Application (2021-2026)
  8. 10.3.2 Asia Preclinical Testing Service Market Size by Application (2027-2032)
  9. 10.3.3 Asia Preclinical Testing Service Market Share by Application (2021-2032)
  10. 10.4 Asia Preclinical Testing Service Market Size by Country
  11. 10.4.1 Asia Preclinical Testing Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Preclinical Testing Service Market Size by Country (2021-2026)
  13. 10.4.3 Asia Preclinical Testing Service Market Size by Country (2027-2032)
  14. 10.4.4 Asia Preclinical Testing Service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Preclinical Testing Service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Preclinical Testing Service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Preclinical Testing Service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Preclinical Testing Service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Preclinical Testing Service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Preclinical Testing Service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Preclinical Testing Service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Preclinical Testing Service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Preclinical Testing Service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Preclinical Testing Service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Preclinical Testing Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Preclinical Testing Service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Preclinical Testing Service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Preclinical Testing Service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst